Crossmark

Synergistic effect of metformin and vemurufenib (PLX4032) as a molecular targeted therapy in anaplastic thyroid cancer: an in vitro study

Published Online: 2021-10-30

Published Print: 2021-11

Authors

Durai, Latha

Ravindran, Soundharya

Arvind, Krishnamurthy

Karunagaran, Devarajan

Vijayalakshmi, Ramshankar
Funding

Funding for this research was provided by:

Board of Research in Nuclear Sciences

Department of Science and Technology, Ministry of Science and Technology
License Information

Text and Data Mining valid from 2021-10-30

Version of Record valid from 2021-10-30
More Information

Article History

Received: 11 May 2021

Accepted: 22 September 2021

First Online: 30 October 2021

Declarations

:

: The authors declare no conflict of interest.

Document is current